Los Angeles Capital Management LLC Curis Inc Transaction History

Los Angeles Capital Management LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 05, 2022	SELL	$0.71 - $2.43 $194,761 - $666,578	-274,312 Reduced 89.99%	30,523 $30,000
Q1 2022 May 06, 2022	BUY	$2.31 - $5.13 $271,096 - $602,046	117,358 Added 62.6%	304,835 $726,000
Q4 2021 Feb 03, 2022	BUY	$4.45 - $8.09 $55,197 - $100,348	12,404 Added 7.09%	187,477 $892,000
Q3 2021 Nov 08, 2021	BUY	$6.94 - $8.85 $1.08 Million - $1.38 Million	155,913 Added 813.74%	175,073 $1.37 Million
Q2 2021 Aug 05, 2021	BUY	$7.45 - $16.27 $142,742 - $311,733	19,160 New	19,160 $155,000

Ticker CRIS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 91,814,704
Market Cap $393M
Description
Curis, Inc., a biotechnology company, engages in the discovery and development of drug candidates for the treatment of human cancers in the United States. Its clinical stage drug candidates include Emavusertib, an oral small molecule drug candidate, which is in a Phase 1/2 clinical trial for the treatment of non-hodgkin lymphomas, and acute myel...

Get notified when there are updates to the investment portfolio of Los Angeles Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Los Angeles Capital Management LLC with notifications on news.